Table 2.
Impact of DAAs intervention on liver function and lipid profiles.
| Variable | Baseline Mean (SD) | SVR24 Mean (SD) | Statistic | Mean Difference | p-Value |
|---|---|---|---|---|---|
| Hb | 14.165 (1.669) |
14.312 (1.411) |
−0.789 | −0.1462 | 0.434 |
| AST | 61.333 (35.933) |
23.043 (7.223) |
8.195 | 38.2892 | <0.001 |
| ALT | 69.941 (47.800) |
18.194 (7.736) |
8.287 | 51.7463 | <0.001 |
| DB | 0.363 (0.235) |
0.230 (0.113) |
4.546 | 0.1338 | <0.001 |
| TB | 0.764 (0.584) |
0.555 (0.313) |
3.598 | 0.2090 | <0.001 |
| TC | 162.245 (37.743) |
182.855 (44.273) |
−3.654 | −20.6094 | <0.001 |
| TG | 103.624 (41.389) |
107.536 (41.339) |
−0.688 | −3.9119 | 0.494 |
| HDLc | 51.523 (14.147) |
53.160 (18.248) |
−0.914 | −1.6363 | 0.365 |
| LDLc | 97.397 (32.565) |
108.629 (34.127) |
−2.937 | −11.2315 | 0.005 |
| ALB | 4.268 (0.431) |
4.184 (0.386) |
0.995 | 0.0847 | 0.333 |
| ALP | 97.596 (49.910) |
80.246 (26.571) |
3.057 | 17.3500 | 0.004 |
| GGT | 82.897 (92.373) |
33.300 (34.629) |
4.148 | 49.5965 | <0.001 |